Today
July 25, 2026Dilution Risk
2Last 7DListing Risk
37Last 30DEarnings
8Last 7DInsider / Ownership
3Last 14DDividends
1Last 30DFDA / Clinical
13Last 30DSunPower registered 22.38M shares for resale by Yorkville under a SEPA.
Registers large selling shareholder block and warrant exercise overhang.
Collab Z amended its S-1 to register 5,000,000 common shares for an IPO.
Quantinuum filed an S-1/A to offer 21.05M Class A shares at $45–$50, planning Nasdaq listing QNT.
Applied Aerospace filed an S‑1/A for a 32.5M‑share IPO, range $18–$21, to list as AADX.
INNIO files S-1/A for 75M-share resale IPO at $24–$27, seeking Nasdaq listing under INIO.
S-1/A registers 6.925M Class A shares at $25–$27; NYSE listing planned.
S-1/A registers 20M shares for NYSE IPO, $13.50–$16.50 price range.
Safepoint files S‑1/A registering 16,666,667 shares for a planned NYSE IPO at $15–$17 per share.
F-1/A registers 6.25M shares, $4–$6 range; Nasdaq listing is not guaranteed.
F-1/A updates IPO registration for 3,335,000 ADSs plus a 1.5M-share resale.
F-1/A registers 6.25M Class A shares; Nasdaq listing pending and governance risks highlighted.
S-1/A corrects an omitted auditor consent and references a going-concern.
S-1/A registers 5,000,000 units at $10 for FWAC SPAC IPO.
2.73M-share primary offering plus warrants will substantially dilute new investors.
S-1/A registers 70.7M shares for Nasdaq direct listing; substantial doubt disclosed.
NervGen raised its shelf to US$250M and applied to list on Nasdaq, but listing is uncertain.
Company files F-1 to sell units while Nasdaq notifies $1 bid-price deficiency.
Firefly registered 12 million shares, combining 4M new shares and 8M resale shares.
Kardigan filed an S‑1 for a Nasdaq IPO and disclosed substantial doubt about its going concern.